3
2
1

Cryonics and Soul Preservation: A Speech by Director Lai Weifu at the Tsinghua Zhongyuan Forum

Release time:

2024-08-13

On August 10th, the fourth Tsinghua Zhongyuan Forum was held in Beijing. The event was hosted by the Clinical Medical College of Tsinghua University, organized by Beijing Tsinghua Changgung Hospital, and co-organized by the Compassionate Care Working Group of the Chinese Anti-Cancer Association. The forum aimed to discuss the wisdom of life in traditional Chinese culture and the practice of hospice care with Chinese characteristics.

Director Lu Guijun from Beijing Tsinghua Changgung Hospital, affiliated with Tsinghua University, delivered a speech titled "Saluting Life, Resonating with Compassion." In his speech, Lu Guijun emphasized the value of professional hospice care teams in the practice of palliative care. He highlighted their role in managing symptoms, responding to humanistic needs, facilitating life reconciliation, honoring the life journey, and addressing comprehensive physical, mental, spiritual, and social demands.

During the keynote speech session, several distinguished guests delivered speeches, including Professor Sun Mingjun from the School of Humanities at Tsinghua University, Professor Lai Weifu, Honorary Director of the Anesthesia Professional Committee of the Shandong Medical Association, writer Zhi An, Professor Zhai Xiaomei from Peking Union Medical College, Vice Dean Song Lilin from the Confucius Culture Research Institute of Qufu Normal University, Deputy Chief Surgeon Tian Meice from the Department of Cardiovascular Surgery at Fuwai Hospital of Chinese Academy of Medical Sciences, and Professor Che Feng from Beijing Normal University.

Among them, Director Lai Weifu delivered a speech titled "Cryonics and Soul Preservation." In his address, Professor Lai Weifu introduced the subtle relationship between end-of-life care and cryonics technology. He stressed that the current medical system should pay attention to the real feelings of terminal patients and their families, face the challenges within the existing medical system, help patients and their families alleviate pain as much as possible, and improve their quality of life. Additionally, Director Lai shared stories behind his role as a promoter and participant in China's first human cryonics operation. He emphasized the role of anesthesia in cryonics and explained the reasons for carrying out cryonics. He believes that cryonics is a medical method that can freeze cancer cells and is a helpless extension of modern medicine and a wait for future medicine. Conducting cryonics has significant implications for organ preservation, reducing patients' fear of death, benefiting national medical research, and exploring interstellar civilization.

Besides the main forum, this year's Tsinghua Zhongyuan Forum included a Youth Forum. The guests shared their thoughts and experiences on topics such as the relationship between life and death, traditional Chinese culture, and the development and dissemination of life and death education. This provided an excellent platform for public life education and enlightenment, contributing to the construction of a hospice care system with Chinese characteristics and achieving the strategic goal of a healthy China.

Latest developments

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.